Search for a Writer:
Calculated Writer Scores
- Frequency of opinion markers: Low
- Sentiment markers: Mostly Neutral
- What is this?
Community Writer Scores
Coverage
- Business: 70%
- Entertainment: 0%
- National: 30%
- Sports: 0%
- Science and Technology: 0%
- World: 0%
Words Associated with THE M A RESEARCHER
Most Frequently Mentioned Topics
Sources They're Writing For (last 60 days)
Writer Feed Widget
Grab this free widget and get the latest news for this writer. You can post it on your web page or blog, or add it to your desktop. Click on the "get & share" button at the bottom.
Articles Written by: THE M A RESEARCHER
Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.
To the Editor: The study by Ikram et al. (April 23 issue)1 was designed to provide information about the risk ...
From KIM, J., CHAE, Y. K., IKRAM, M. A., SESHADRI, S., BIS, J. C., THE COHORTS IN HEART AND AGING RESEARCH CONSORTIUM,
New England Journal of Medicine -- Recent Issues,
12 Aug 2009
George M. Savva, Ph.D., Stephen B. Wharton, F.R.C.Path., Paul G. Ince, M.D., Gillian Forster, B.Sc., Fiona E. Matthews, Ph.D., Carol Brayne, M.D., for the Medical Research Council ...
From SAVVA, G. M., WHARTON, S. B., INCE, P. G., FORSTER, G., MATTHEWS, F. E., BRAYNE, C., THE MEDICAL RESEARCH COUNCIL COGNITIVE FUNCTION AND AGEING STUDY,
New England Journal of Medicine -- Recent Issues,
27 May 2009
Background Although numerous studies have explored the benefit of using nebulized epinephrine or corticosteroids alone to treat infants with bronchiolitis, the effectiveness of combining these medications is not well established.
Methods We conducted ...
From PLINT, A. C., JOHNSON, D. W., PATEL, H., WIEBE, N., CORRELL, R., BRANT, R., MITTON, C., GOUIN, S., BHATT, M., JOUBERT, G., BLACK, K. J.L., TURNER, T., WHITEHOUSE, S., KLASSEN, T. P., PEDIATRIC EMERGENCY RESEARCH CANADA,
New England Journal of Medicine -- Recent Issues,
13 May 2009
Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.
To the Editor: In their report on the Avoiding Cardiovascular Events through Combination Therapy in Patients ...
From PARRA, D., ROSENSTEIN, R., STRAUSS, M. H., WEINSTEIN, J., NEWTON, G. E., DAVIS, B. R., WHELTON, P. K., THE ALLHAT COLLABORATIVE RESEARCH GROUP, JAMERSON, K. A., WEBER, M. A.,
New England Journal of Medicine -- Recent Issues,
11 Mar 2009
Agrium (AGR) has announced a $72.00 per share offer for CF Industries (CF), valuing the company at $3.6b.
This action by AGR is very clearly an attempt to prevent the possible Terra Industries (TRA) - CF combination which would threaten AGR's top ...
From THE M & A RESEARCHER,
ETF Investor,
2 Mar 2009
Rohm Haas Co. (ROH) shareholders have approved its merger with Dow Chemical Co. (DOW).
The companies continue to project a close in early 2009.
It will be noted again that the European Commission has not yet started its formal review of this ...
From THE M & A RESEARCHER,
Seeking Alpha,
30 Oct 2008
In the case of Wachovia (WB) - Wells Fargo (WFC), it seem far more prudent, if not an absolutely necessity, to assess the Citigroup (C) / FDIC aspect, rather than focus on the dynamics of the WB-WFC transaction. First and foremost, it must be pointed ...
From THE M & A RESEARCHER,
Seeking Alpha,
7 Oct 2008
Cleveland-Cliffs Inc (CLF) shareholders rejected Harbinger Capital's control share acquisition on October 3, 2008. A CLF press releases states the following:
[B]ased on the preliminary count provided by its proxy solicitor, it appears that ...
From THE M & A RESEARCHER,
Seeking Alpha,
7 Oct 2008
Alpharma (ALO) has announced the rejection of King Pharmaceuticals' (KG) unsolicited $37 per share offer as "financially inadequate."
ALO has also disclosed the following with respect to third-party interest:
We believe other offers or alternatives to ...
From THE M & A RESEARCHER,
ETF Investor,
29 Sep 2008
The Datascope Corp. (DSCP) - Getinge AB combination may present some fairly complex issues in the area of vascular/cardiac devices as a result of Getinge acquiring Boston Scientific's (BSX) cardiac surgery and vascular division last year.
At present, ...
From THE M & A RESEARCHER,
ETF Investor,
29 Sep 2008
